Clinical Trial Update: Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating erlotinib with radiation therapy and chemotherapy for inoperable Stage III non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Bronchioloalveolar Carcinoma
• Large Cell Lung Cancer
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung
• Stage Iiia Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer | Phase 1 | Status: TERMINATED